3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
3
Fluorodeoxyglucose F18
3
pembrolizumab
2
Radiosurgery
2
Paclitaxel
2
Nivolumab
2
Ipilimumab
2
FAPI-46
2
tipifarnib
1
sodium thiosulfate
1
sargramostim
1
regorafenib
1
montelukast
1
entrectinib
1
entinostat
1
cediranib
1
cc-486
1
carboxyamido-triazole
1
alectinib
1
aflibercept
1
Trastuzumab
1
Thiotepa
1
Tablets
1
Specimen Handling
1
Sirolimus
1
Sevoflurane
1
Ritonavir
1
Restraint, Physical
1
Radiotherapy
1
Quality of Life
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Patient-Specific Modeling
×
Gynecologic
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn